Abbott Laboratories Q3 Earnings Surpass Expectations with 4.9% Revenue Growth

Abbott Laboratories has reported a significant increase in its third-quarter profits, surpassing analysts' expectations. The company's earnings for the quarter reached $1.646 billion, translating to $0.94 per share, compared to $1.436 billion or $0.82 per share in the same period last year. When excluding certain items, Abbott's adjusted earnings were $2.119 billion or $1.21 per share, slightly above the anticipated $1.20 per share predicted by analysts.

The revenue for Abbott Laboratories also showed growth, rising by 4.9% to $10.635 billion from $10.143 billion in the previous year. This performance reflects the company's robust financial health and operational efficiency.

Looking ahead, Abbott has provided guidance for the next quarter, with expected earnings per share (EPS) ranging from $1.31 to $1.37. The full-year EPS is projected to be between $4.64 and $4.70, indicating continued confidence in its financial trajectory.